Nanoparticles in cellular drug delivery.

This review highlights the properties of nanoparticles used in targeted drug delivery, including delivery to cells as well as organelle targets, some of the known pharmacokinetic properties of nanoparticles, and their typical modifications to allow for therapeutic delivery. Nanoparticles exploit biological pathways to achieve payload delivery to cellular and intracellular targets, including transport past the blood-brain barrier. As illustrative examples of their utility, the evaluation of targeted nanoparticles in the treatment of cancers and diseases of the central nervous system, such as glioblastoma multiforme, neurovascular disorders, and neurodegenerative diseases, is discussed.

[1]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[2]  Christopher J. Destache,et al.  Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System , 2006, Journal of Neuroimmune Pharmacology.

[3]  A. P. Alivisatos,et al.  Epitaxial growth and photochemical annealing of graded CdS/ZnS shells on colloidal CdSe nanorods. , 2002, Journal of the American Chemical Society.

[4]  G. Ozin,et al.  Non-aqueous supramolecular assembly of mesostructured metal germanium sulphides from (Ge4S10)4− clusters , 1999, Nature.

[5]  M. Pshirkov,et al.  Weak microlensing effect and stability of pulsar time scale , 2006, astro-ph/0610681.

[6]  G. Frens.  Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .

[7]  L M Gan,et al.  Processing of hydroxyapatite via microemulsion and emulsion routes. , 1997, Biomaterials.

[8]  M. Faraday.  X. The Bakerian Lecture. —Experimental relations of gold (and other metals) to light , 1857, Philosophical Transactions of the Royal Society of London.

[9]  M. Johnson,et al.  Fullerenes C60 and C70 in flames , 1991, Nature.

[10]  E. Blakely,et al.  Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. , 2000, Cancer research.

[11]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[12]  Taeghwan Hyeon,et al.  Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. , 2001, Journal of the American Chemical Society.

[13]  J. Fendler.  Atomic and molecular clusters in membrane mimetic chemistry , 1987 .

[14]  David D Spragg,et al.  Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Cai,et al.  BACE1 is the major β-secretase for generation of Aβ peptides by neurons , 2001, Nature Neuroscience.

[16]  R. Firestone,et al.  Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. , 1994, Bioconjugate chemistry.

[17]  Constantinos Sioutas,et al.  Potential Role of Ultrafine Particles in Associations between Airborne Particle Mass and Cardiovascular Health , 2005, Environmental health perspectives.

[18]  G. H. Nancollas,et al.  The seeded growth of calcium phosphates. The effect of solid/solution ratio in controlling the nature of the growth phase , 1977 .

[19]  C. Toniolo,et al.  Gold nanoclusters protected by conformationally constrained peptides. , 2006, Journal of the American Chemical Society.

[20]  Toshifumi Sakaguchi,et al.  Magnetite formation by a sulphate-reducing bacterium , 1993, Nature.

[21]  Y. Barenholz,et al.  Gelation of liposome interior A novel method for drug encapsulation , 1992, FEBS letters.

[22]  M. Brightman,et al.  Morphology of blood-brain interfaces. , 1977, Experimental eye research.

[23]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[24]  David M. Brown,et al.  The Role of Free Radicals in the Toxic and Inflammatory Effects of Four Different Ultrafine Particle Types , 2003, Inhalation toxicology.

[25]  Patrick Couvreur,et al.  Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat , 2002, The European journal of neuroscience.

[26]  Richard L. Verrier,et al.  Association of Air Pollution with Increased Incidence of Ventricular Tachyarrhythmias Recorded by Implanted Cardioverter Defibrillators , 2005, Environmental health perspectives.

[27]  Seong Huh,et al.  Organic Functionalization and Morphology Control of Mesoporous Silicas via a Co-Condensation Synthesis Method , 2003 .

[28]  R. Misra,et al.  Biomaterials , 2008 .

[29]  A. P. Alivisatos,et al.  A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides , 1999 .

[30]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[31]  V. Labhasetwar,et al.  Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. , 2004, Molecular pharmaceutics.

[32]  S. Stupp,et al.  Semiconducting superlattices templated by molecular assemblies , 1996, Nature.

[33]  P. Needleman,et al.  The transformation of glyceryl trinitrate and other nitrates by glutathione-organic nitrate reductase. , 1965, Molecular pharmacology.

[34]  J. B. Higgins,et al.  A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .

[35]  Avelino Corma,et al.  Hierarchically mesostructured doped CeO2 with potential for solar-cell use , 2004, Nature materials.

[36]  X. B. Zhang,et al.  The study of carbon nanotubules produced by catalytic method , 1994 .

[37]  C. Rao,et al.  Carbon nanotubes from organometallic precursors. , 2002, Accounts of chemical research.

[38]  S. Iijima.  Helical microtubules of graphitic carbon , 1991, Nature.

[39]  G. A. Dyuzhev,et al.  Fullerene formation in an arc discharge , 2003 .

[40]  María Vallet-Regí,et al.  Mesoporous materials for drug delivery. , 2007, Angewandte Chemie.

[41]  N. Rodriguez,et al.  A review of catalytically grown carbon nanofibers , 1993 .

[42]  V. Labhasetwar,et al.  Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. , 2004, Molecular pharmaceutics.

[43]  P. Ponka,et al.  Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism , 1998, American journal of hematology.

[44]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[45]  A. Peters,et al.  Increased plasma viscosity during an air pollution episode: a link to mortality? , 1997, The Lancet.

[46]  James McBride,et al.  Targeting cell surface receptors with ligand-conjugated nanocrystals. , 2002, Journal of the American Chemical Society.

[47]  R. Burnett,et al.  Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution: Epidemiological Evidence of General Pathophysiological Pathways of Disease , 2003, Circulation.

[48]  Yewei Xu,et al.  Hydrothermal conversion of coral into hydroxyapatite , 2001 .

[49]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[50]  Weihong Tan,et al.  Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[51]  David M. Brown,et al.  Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.

[52]  J. Gutteridge.  Hydroxyl Radicals, Iron, Oxidative Stress, and Neurodegeneration a , 1994, Annals of the New York Academy of Sciences.

[53]  T. Matsunaga,et al.  Biomagnetic nanoparticle formation and application , 1998 .

[54]  N. Bressler,et al.  Randomized clinical trials in ophthalmology in 2001: twenty-fifth anniversary of the first publication from the Diabetic Retinopathy Study. , 2001, American journal of ophthalmology.

[55]  S. Caruthers,et al.  Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. , 2004, Current pharmaceutical biotechnology.

[56]  B. Sabel,et al.  Nanoparticle technology for delivery of drugs across the blood-brain barrier. , 1998, Journal of pharmaceutical sciences.

[57]  M. Miki-Yoshida,et al.  Catalytic growth of carbon microtubules with fullerene structure , 1993 .

[58]  W. Tong,et al.  Manganese oxide mesoporous structures: Mixed-valent semiconducting catalysts , 1997 .

[59]  V. Labhasetwar,et al.  Targeting intracellular targets. , 2004, Current drug delivery.

[60]  S. Moghimi.  Modulation of lymphatic distribution of subcutaneously injected poloxamer 407‐coated nanospheres: the effect of the ethylene oxide chain configuration , 2003, FEBS letters.

[61]  I. Fridovich,et al.  Aluminum(III) facilitates the oxidation of NADH by the superoxide anion. , 1992, Free radical biology & medicine.

[62]  M. Kanatzidis,et al.  Varied pore organization in mesostructured semiconductors based on the [SnSe4]4- anion , 2001, Nature.

[63]  A. Oseroff,et al.  Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  David G. Evans,et al.  Preparation of Layered Double-Hydroxide Nanomaterials with a Uniform Crystallite Size Using a New Method Involving Separate Nucleation and Aging Steps , 2002 .

[65]  V. Fuster,et al.  Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. , 2005, JAMA.

[66]  S. Tolbert,et al.  Hexagonal nanoporous germanium through surfactant-driven self-assembly of Zintl clusters , 2006, Nature.

[67]  H. Keberle.  The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism , 1964, Annals of the New York Academy of Sciences.

[68]  D. Dockery,et al.  An association between air pollution and mortality in six U.S. cities. , 1993, The New England journal of medicine.

[69]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[70]  N. Plesnila,et al.  Lipid–sugar particles for intracranial drug delivery: safety and biocompatibility , 2002, Brain Research.

[71]  Andrew H. Kaye,et al.  Brain tumors : an encyclopedic approach , 2001 .

[72]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[73]  D. Louis,et al.  Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. , 2002, Journal of biomedical materials research.

[74]  L Davies,et al.  Bone marrow transplant. , 1985, Nursing times.

[75]  P. Magusin,et al.  Hollow silica spheres with an ordered pore structure and their application in controlled release studies. , 2006, Chemistry.

[76]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[77]  P. Couvreur,et al.  Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.

[78]  S. Ng,et al.  Formation of Nanocrystalline Hydroxyapatite in Nonionic Surfactant Emulsions , 1999 .

[79]  James Mack,et al.  A Rational Chemical Synthesis of C60 , 2002, Science.

[80]  T. Osaka,et al.  Surface modification of γ-Fe2O3 nanoparticles with aminopropylsilyl groups and interparticle linkage with α,ω-dicarboxylic acids , 2005 .

[81]  S. Manna,et al.  Single-Walled Carbon Nanotube Induces Oxidative Stress and Activates Nuclear Transcription Factor-κB in Human Keratinocytes , 2005 .

[82]  A. Pardi,et al.  A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[84]  José Rivas,et al.  Advances in the Preparation of Magnetic Nanoparticles by the Microemulsion Method , 1997 .

[85]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[86]  R. Virmani,et al.  Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel , 2002, Circulation.

[87]  A. Govindaraj,et al.  Synthesis of multi-walled and single-walled nanotubes, aligned-nanotube bundles and nanorods by employing organometallic precursors , 1998 .

[88]  K. Kandori,et al.  Preparation and characterization of monodisperse magnetite sols in microemulsion , 1983 .

[89]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[90]  Bradley F. Chmelka,et al.  Generalized syntheses of large-pore mesoporous metal oxides with semicrystalline frameworks , 1998, Nature.

[91]  P. Volberding,et al.  Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.

[92]  R. Langer,et al.  Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. , 2006, Journal of biomedical materials research. Part A.

[93]  S. Bachilo,et al.  Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. , 2004, Journal of the American Chemical Society.

[94]  Moghimi,et al.  Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. , 1999, Advanced drug delivery reviews.

[95]  O. Rosen,et al.  Pegylated asparaginase in combination with high‐dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study , 2003, British journal of haematology.

[96]  P. Baron,et al.  Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[97]  Amane Shiohara,et al.  On the Cyto‐Toxicity Caused by Quantum Dots , 2004, Microbiology and immunology.

[98]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[99]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[100]  Shinsuke Sando,et al.  A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. , 2004, Journal of the American Chemical Society.

[101]  M. Schoenfisch,et al.  Synthesis of nitric oxide-releasing gold nanoparticles. , 2005, Journal of the American Chemical Society.

[102]  T. Hirai,et al.  The Preparation of Spherical Calcium Phosphate Fine Particles Using an Emulsion Liquid Membrane System , 2000 .

[103]  Victor S-Y Lin,et al.  Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.

[104]  M McCarthy,et al.  Hepatology , 1999, Rapid Medicine.

[105]  J. E. Adams.  Brain Tumors: An Encyclopedic Approach , 1996 .

[106]  Robert Langer,et al.  Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.

[107]  Gregory Stephanopoulos,et al.  Dynamics of gene silencing by RNA interference , 2004, Biotechnology and bioengineering.

[108]  M. Pileni,et al.  In situ synthesis of silver nanocluster in AOT reverse micelles , 1993 .

[109]  C. Olanow,et al.  An introduction to the free radical hypothesis in Parkinson's disease , 1992, Annals of neurology.

[110]  Peter Ramge,et al.  Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.

[111]  T. Niidome,et al.  Artificial viruses and their application to gene delivery. Size-controlled gene coating with glycocluster nanoparticles. , 2003, Journal of the American Chemical Society.

[112]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[113]  V. Castranova,et al.  Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. , 2006, Toxicology letters.

[114]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[115]  Yoshiaki,et al.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. , 1999, International journal of pharmaceutics.

[116]  Daniel S Kohane,et al.  Microparticles and nanoparticles for drug delivery. , 2007, Biotechnology and bioengineering.

[117]  F. Muggia,et al.  Phase III data on Caelyx in ovarian cancer. , 2001, European journal of cancer.

[118]  Kerry K. Karukstis,et al.  Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.

[119]  K. Marder.  Memantine approved to treat moderate to severe Alzheimer’s disease , 2004, Current Neurology and Neuroscience Reports.

[120]  P. Albouy,et al.  Periodically ordered nanoscale islands and mesoporous films composed of nanocrystalline multimetallic oxides , 2004, Nature materials.

[121]  D. Begley,et al.  Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles , 2003, Pharmaceutical Research.

[122]  W. Krätschmer,et al.  Solid C60: a new form of carbon , 1990, Nature.

[123]  Hao Zeng,et al.  Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.

[124]  Chenjie Xu,et al.  Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. , 2008, Journal of the American Chemical Society.

[125]  V. Labhasetwar,et al.  Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression , 2004, Pharmaceutical Research.

[126]  S. Bondy,et al.  Promotion of transition metal-induced reactive oxygen species formation by β-amyloid , 1998, Brain Research.

[127]  S. Miller,et al.  Molecular structure and biological and pharmacological properties of 3-hydroxy-2-methyl-1-(beta-D-ribofuranosyl or pyranosyl)-4-pyridinone: potential iron overload drugs for oral administration. , 1998, Bioorganic & medicinal chemistry letters.

[128]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[129]  J. Lunec,et al.  Cerebral and ocular toxicity induced by desferrioxamine. , 1985, The Quarterly journal of medicine.

[130]  C. Rao,et al.  Single-walled nanotubes by the pyrolysis of acetylene-organometallic mixtures , 1998 .

[131]  A. Ostafin,et al.  Liposome directed growth of calcium phosphate nanoshells , 2002 .

[132]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[133]  G. Wolstenholme,et al.  Taste and smell in vertebrates , 1970 .

[134]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[135]  J. G. Miller,et al.  In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[136]  S. Phuphanich,et al.  Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[138]  N. Higashi,et al.  Preparation of helical peptide monolayer-coated gold nanoparticles. , 2005, Journal of colloid and interface science.

[139]  H. Feldman,et al.  Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease , 1996, Nature Medicine.

[140]  P. Midgley,et al.  Direct imaging of single-walled carbon nanotubes in cells. , 2007, Nature nanotechnology.

[141]  G. Armatas,et al.  Mesostructured germanium with cubic pore symmetry , 2006, Nature.

[142]  P. Constantinides,et al.  Plaque fissures in human coronary thrombosis , 1966 .

[143]  Jin-Ho Choy,et al.  Inorganic Layered Double Hydroxides as Nonviral Vectors , 2000 .

[144]  A. Bangham.  Surrogate cells or Trojan horses. The discovery of liposomes. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[145]  R. Hider,et al.  Clinically useful chelators of tripositive elements. , 1991, Progress in medicinal chemistry.

[146]  T. V. van Berkel,et al.  Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. , 2001, Advanced drug delivery reviews.

[147]  S. Caruthers,et al.  1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles , 2004 .

[148]  J. Carson,et al.  Air Pollution and Brain Damage , 2002, Toxicologic pathology.

[149]  K. Dreher,et al.  Oxidative Stress Mediates Air Pollution Particle-Induced Acute Lung Injury and Molecular Pathology , 2003, Inhalation toxicology.

[150]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.

[151]  Anisha Goel,et al.  Reaction rate coefficient of fullerene (C60) consumption by soot , 2003 .

[152]  José Rivas,et al.  Chemical Reactions in Microemulsions: A Powerful Method to Obtain Ultrafine Particles , 1993 .

[153]  J. M. Harris,et al.  Pegylation: a novel process for modifying pharmacokinetics. , 2001, Clinical pharmacokinetics.

[154]  D. Zhao,et al.  Self-adjusted synthesis of ordered stable mesoporous minerals by acid–base pairs , 2003, Nature materials.

[155]  Michael O'Keeffe,et al.  A mesoporous germanium oxide with crystalline pore walls and its chiral derivative , 2005, Nature.

[156]  R. Bulman,et al.  The present status of chelating agents in medicine. , 1983, Progress in medicinal chemistry.

[157]  A. Govindaraj,et al.  Carbon nanotubes by the metallocene route , 1997 .

[158]  W. Pardridge,et al.  Drug and gene targeting to the brain with molecular trojan horses , 2002, Nature Reviews Drug Discovery.

[159]  M. Bawendi,et al.  (CdSe)ZnS Core-Shell Quantum Dots - Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystallites , 1997 .

[160]  K. Prasad,et al.  Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. , 2000, Clinical neuropharmacology.

[161]  R. Boulieu,et al.  Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. , 1991, Advances in experimental medicine and biology.

[162]  Jong-sang Park,et al.  Cellular uptake behavior of [γ-32P] labeled ATP–LDH nanohybrids , 2001 .

[163]  Abraham Ulman,et al.  Sonochemical synthesis of functionalized amorphous iron oxide nanoparticles , 2001 .

[164]  Gang Liu,et al.  Acyclonucleoside Iron Chelators of 1‐(2‐Hydroxyethoxy)methyl‐2‐alkyl‐3‐hydroxy‐4‐pyridinones: Potential Oral Iron Chelation Therapeutics , 2004, Nucleosides, nucleotides & nucleic acids.

[165]  J. Nagy,et al.  Catalytic synthesis and purification of carbon nanotubes , 1996 .

[166]  V. Richardson,et al.  POTENTIAL APPLICATIONS OF LIPOSOMES TO THERAPY * , 1978, Annals of the New York Academy of Sciences.

[167]  J. Storhoff,et al.  Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. , 1997, Science.

[168]  A. Wear.  CIRCULATION , 1964, The Lancet.

[169]  L. Recht,et al.  A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[170]  A. Gedanken,et al.  Synthesis of pure amorphous Fe_2O_3 , 1997 .

[171]  J. Coyle,et al.  Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer’s disease , 2001, Biological Psychiatry.

[172]  Xudong Huang,et al.  Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[173]  M. Piccart,et al.  A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer. , 2003, Oncology reports.

[174]  Philip N. Bartlett,et al.  Mesoporous Platinum Films from Lyotropic Liquid Crystalline Phases , 1997 .

[175]  T. Kruck,et al.  A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate , 1993, Clinical pharmacology and therapeutics.

[176]  G. Lagaly,et al.  Anion-exchange reactions of hydroxy double salts , 1993 .

[177]  W. Stöber,et al.  Controlled growth of monodisperse silica spheres in the micron size range , 1968 .

[178]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001 .

[179]  K. L. Yadav,et al.  Formation of hydroxyapatite in water, Hank's solution, and serum at physiological temperature. , 2003, Journal of biomedical materials research. Part A.

[180]  Samir K. Gupta,et al.  A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C , 2000 .

[181]  M Epple,et al.  A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. , 2004, Biomaterials.

[182]  W. Kreyling,et al.  Translocation of Inhaled Ultrafine Particles to the Brain , 2004, Inhalation toxicology.

[183]  Gang Liu,et al.  SYNTHESIS OF LIPOPHILIC 3-HYDROXY-2-METHYL-4-PYRIDINONE DERIVATIVES , 1995 .

[184]  M. Prato,et al.  Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[185]  A. Ceribelli,et al.  Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[186]  K. Longmuir,et al.  Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence , 2006, Pharmaceutical Research.

[187]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.

[188]  U. Mandal,et al.  Synthesis of nanocrystalline calcium phosphate in microemulsion--effect of nature of surfactants. , 2008, Journal of colloid and interface science.

[189]  Y. Vasil’ev,et al.  Groundwork for a Rational Synthesis of C60: Cyclodehydrogenation of a C60H30 Polyarene , 2001, Science.

[190]  Pierre M. Petroff,et al.  Generalized synthesis of periodic surfactant/inorganic composite materials , 1994, Nature.

[191]  A. Ulman,et al.  Formation and Structure of Self-Assembled Monolayers. , 1996, Chemical reviews.

[192]  R. Müller,et al.  Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery , 1995 .

[193]  T. Budinger,et al.  Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[194]  W. MacNee,et al.  Particulate air pollution and acute health effects , 1995, The Lancet.

[195]  Neil Desai,et al.  Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[196]  Christopher G Thanos,et al.  Targeted nanoparticle-based drug delivery and diagnosis , 2007, Journal of drug targeting.

[197]  Huajian Gao,et al.  Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[198]  M. Farlow,et al.  Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine. , 2001, Clinical therapeutics.

[199]  Fabrizio Cavani,et al.  Hydrotalcite-type anionic clays: Preparation, properties and applications. , 1991 .

[200]  G. Lu,et al.  Dispersion and size control of layered double hydroxide nanoparticles in aqueous solutions. , 2006, The journal of physical chemistry. B.

[201]  T. Pinnavaia,et al.  Basic Properties of Mg2+1-xAl3+x Layered Double Hydroxides Intercalated by Carbonate, Hydroxide, Chloride, and Sulfate Anions , 1995 .

[202]  Maureen R. Gwinn,et al.  Nanoparticles: Health Effects—Pros and Cons , 2006, Environmental health perspectives.

[203]  T. Nyholm,et al.  Nucleosides Nucleotides Nucleic Acids , 2003 .

[204]  K. Suslick,et al.  Sonochemical Synthesis of Iron Colloids , 1996 .

[205]  Lawrence T Scott,et al.  Methods for the chemical synthesis of fullerenes. , 2004, Angewandte Chemie.

[206]  P. Guyot-Sionnest,et al.  Synthesis and Characterization of Strongly Luminescing ZnS-Capped CdSe Nanocrystals , 1996 .

[207]  Y. Aoyama,et al.  Remarkably size-regulated cell invasion by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery. , 2003, Journal of the American Chemical Society.

[208]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[209]  Mathias Brust,et al.  Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .

[210]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[211]  C. Gorman.  Heart disease. Rethinking treatments for the heart. , 2001, Time.

[212]  A. Boskey,et al.  Conversion of amorphous calcium phosphate to microcrystalline hydroxyapatite. A pH-dependent, solution-mediated, solid-solid conversion , 1973 .

[213]  D. A. Kharkevich,et al.  Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles , 1997, Pharmaceutical Research.

[214]  Indrajit Roy,et al.  Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. , 2003, International journal of pharmaceutics.

[215]  S. Lynch,et al.  A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis. , 2000, Cellular and molecular biology.